IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

5AM Venture Management, LLC

Q4 2024 Holdings

Filed 2025-02-14 | 31 holdings | $419.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Entrada Therapeutics Inc(TRDA)COM29384C108$76.2M4,408,37918.2%
Enliven Therapeutics Inc(ELVN)COM29337E102$36.7M1,629,7658.8%
Skye Bioscience Inc(SKYE)COM NEW83086J200$28.1M9,913,1686.7%
Tectonic Therapeutic Inc(TECX)COM878972108$27.5M596,6606.6%
Artiva Biotherapeutics Inc(ARTV)COM04317A107$23.7M2,353,3045.7%
Dianthus Therapeutics Inc(DNTH)COM252828108$22.4M1,027,7115.3%
Biohaven LTD(BHVN)COMG1110E107$17.9M478,9724.3%
Pharvaris N V(PHVS)COMN69605108$15.3M797,6003.6%
Moonlake Immunotherapeutics(MLTX)CLASS A ORD61559X104$15.3M282,3133.6%
Camp4 Therapeutics Corp(CAMP)COM13463J101$15.3M2,927,9153.6%
Viridian Therapeutics Inc(VRDN)COM92790C104$14.1M736,5953.4%
Centessa Pharmaceuticals PLC(CNTA)SPONSORED ADS152309100$13.9M830,9453.3%
Erasca Inc(ERAS)COM29479A108$13.6M5,405,4043.2%
Praxis Precision Medicines I(PRAX)COM NEW74006W207$13.1M170,0003.1%
Tyra Biosciences Inc(TYRA)COM90240B106$13.1M939,2983.1%
Celldex Therapeutics Inc New(CLDX)COM NEW15117B202$12.6M497,2703.0%
Eyepoint Pharmaceuticals Inc(EYPT)COM NEW30233G209$7.8M1,050,0001.9%
Viking Therapeutics Inc(VKTX)COM92686J106$7.6M189,5931.8%
VOR Biopharma IncCOM929033108$7.1M6,361,7231.7%
Anaptysbio Inc(ANAB)COM032724106$4.7M357,7331.1%
Akero Therapeutics Inc(AKRO)COM00973Y108$4.6M165,0001.1%
Scpharmaceuticals Inc(SCPH)COM810648105$4.3M1,200,6471.0%
Protara Therapeutics Inc(TARA)COM STK74365U107$4.2M800,0001.0%
GH Research PLC(GHRS)ORDINARY SHARESG3855L106$4.0M572,6651.0%
Rallybio CorpCOM75120L100$3.5M3,630,7240.8%
Silence Therapeutics PLC(SLN)ADS82686Q101$3.3M476,2000.8%
Adverum Biotechnologies Inc(AVU0)COM NEW00773U207$2.5M541,6660.6%
Alector Inc(ALEC)COM014442107$1.9M995,8410.4%
Mersana Therapeutics IncCOM59045L106$1.9M1,305,0000.4%
Cidara Therapeutics Inc(CDTX)COM NEW171757206$1.5M56,7250.4%
Zentalis Pharmaceuticals Inc(ZNTL)COM98943L107$1.5M490,0000.4%